Adaptive Biotechnologies (ADPT) FCF Margin Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) FCF Margin Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 379.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 183.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -328.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 454.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 97.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 1,284.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -537.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 590.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -697.00 |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn | 1,162.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,162.00 |
| Mar 31, 2026 | 4,214.00 |
| Dec 31, 2025 | 2,847.00 |
| Sep 30, 2025 | 5,101.00 |
| Jun 30, 2025 | 2,184.00 |
| Mar 31, 2025 | 3,849.00 |
| Dec 31, 2024 | 3,517.00 |
| Sep 30, 2024 | 7,141.00 |
| Jun 30, 2024 | 30,987.00 |
| Mar 31, 2024 | 6,969.00 |
| Dec 31, 2023 | -267.00 |
| Sep 30, 2023 | -3,042.00 |
| Jun 30, 2023 | -23,400.00 |
| Mar 31, 2023 | 997.00 |
| Dec 31, 2022 | 10,729.00 |
| Sep 30, 2022 | 4,709.00 |
| Jun 30, 2022 | 3,395.00 |
| Mar 31, 2022 | 1,786.00 |
| Dec 31, 2021 | -324.00 |
| Sep 30, 2021 | 4,819.00 |